Abstract:Introduction: Neuronal death and proinflammatory microglial reactions both contribute to ischemic/reperfusion (I/R) brain injury. However, the molecular interplay of these two events is poorly understood.Hypothesis: Activation of ASK1, a key MAPKKK upstream of JNK and p38 MAPK signaling cascades, mediates neuronal death and microglial neurotoxicity after I/R.Methods: We created ASK1 kinase dead knock-in mice (ASK1-ki, K716R) with universal loss of ASK1 kinase activity. Brain injury and neurobehavioral deficits were assessed after 1h MCAO and reperfusion. Cell-permeable small peptides mimicking the docking sites on ASK1 for MKK3/6 (TAT-M3i) or MKK4/7 (TAT-M4i) were delivered into primary neurons and microglia, or into mice intranasally to inhibit ASK1-mediated p38 or JNK signaling, respectively.Results: MCAO induced robust ASK1/JNK/p38 activation in WT but not in ASK1-ki mice. ASK1-ki mice had reduced infarct (by 41.8%, p≤0.01, n=8) and improved sensorimotor and cognitive functions up to 28d vs. WT littermates. In primary cultures, OGD-induced neuronal death was attenuated in ASK1-ki neurons or in WT neurons treated with TAT-M4i. Conditioned medium from post-OGD neurons stimulated microglia toward the cytotoxic M1 phenotype, promoting the release of neurotoxic cytokines and NO. These responses were suppressed in ASK1-ki microglia, or WT microglia treated with TAT-M3i or p38α shRNA. Consistently, ASK1-ki mice had markedly reduced microglial M1 (but not M2) markers and proinflammatory cytokines after MCAO vs. WT. Finally, intranasal delivery of TAT-M4i and TAT-M3i (2, 24, and 48h after MCAO), but not either peptide alone, conferred long-term protection and improved sensorimotor/cognitive performance of WT mice up to 35d.Conclusions: ASK1 is an essential mediator of prodeath neuron-microglia interactions after I/R. Inhibiting ASK1 signaling is a promising and clinically feasible strategy to achieve sustained protection after stroke. ![][1] [1]: /embed/graphic-1.gif

Induction of Apoptosis by ASK1, a Mammalian MAPKKK That Activates SAPK/JNK and P38 Signaling Pathways

AIP1 Recruits Phosphatase PP2A to ASK1 in Tumor Necrosis Factor–Induced ASK1-JNK Activation

The regulatory and signaling mechanisms of the ASK family

JAK2 and SHP2 Reciprocally Regulate Tyrosine Phosphorylation and Stability of Proapoptotic Protein ASK1.

ASK1 Is Essential for JNK/SAPK Activation by TRAF2

Therapeutic potential of ASK1 activators in cancer treatment: Current insights and future directions

MAPK/JNK Signalling: a Potential Autophagy Regulation Pathway

Role of Mitogen‐activated Protein Kinases in Activation‐induced Apoptosis of T Cells

MAPK/JNK signaling: A potential autophagy regulation pathway.

Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis

p38MAPK Signal Transduction Pathway and Cell Apoptosis

TGFβ Activates Mitogen- and Stress-activated Protein Kinase-1 (MSK1) to Attenuate Cell Death

Apoptosis signal-regulating kinase 1 promotes inflammation in senescence and aging

DAPK Mediates TNF‐alpha Induced Apoptosis by TNF‐receptor 1 Association and JNK Activation Through MKK7

Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis

Apoptosis signal-regulating kinase 1 (ASK1) inhibition reduces endothelial cytokine production without improving permeability after toll-like receptor 4 (TLR4) challenge

C-Jun N-Terminal Kinase Enhances Mst1-Mediated Pro-Apoptotic Signaling Through Phosphorylation At Serine 82

Selective activation of the c-Jun N-terminal kinase (JNK) pathway fails to elicit Bax activation or apoptosis unless the phosphoinositide 3′-kinase (PI3K) pathway is inhibited

Understanding MAPK Signaling Pathways in Apoptosis

Aberrant Activation of ASK1 Mediates Proinflammatory and Neurotoxic Microglial Responses After Cerebral Ischemia/Reperfusion

Editor's Note: P38 Mitogen-activated Protein Kinase Pathway Suppresses Cell Survival by Inducing Dephosphorylation of Mitogen-activated Protein/Extracellular Signal-regulated Kinase Kinase1,2